Literature DB >> 3477813

Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification.

A J Wong1, S H Bigner, D D Bigner, K W Kinzler, S R Hamilton, B Vogelstein.   

Abstract

Primary malignant gliomas from 63 patients were analyzed to determine the relationship between amplification of the gene encoding the epidermal growth factor receptor (EGFR) and expression of the corresponding mRNA. Twenty-four tumors were found to have amplified the EGFR gene and amplification of other genes occurred in three additional tumors. Hybridization with synthetic RNA probes was used to quantitate mRNA levels in situ. All 24 tumors with amplification of the EGFR gene had high levels of expression of this gene, while none of the 39 tumors without amplification had increased levels. This shows that, in human gliomas, large increases in the expression of the EGFR gene are invariably associated with alterations in gene structure.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3477813      PMCID: PMC299192          DOI: 10.1073/pnas.84.19.6899

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Increased expression of the c-myc gene without gene amplification in human lung cancer and colon cancer cell lines.

Authors:  K Yoshimoto; S Hirohashi; T Sekiya
Journal:  Jpn J Cancer Res       Date:  1986-06

2.  Chromosomal evolution in malignant human gliomas starts with specific and usually numerical deviations.

Authors:  S H Bigner; J Mark; D E Bullard; M S Mahaley; D D Bigner
Journal:  Cancer Genet Cytogenet       Date:  1986-06

3.  Variation among human 28S ribosomal RNA genes.

Authors:  I L Gonzalez; J L Gorski; T J Campen; D J Dorney; J M Erickson; J E Sylvester; R D Schmickel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

Review 4.  Mechanisms of tumor progression.

Authors:  P C Nowell
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

Review 5.  Selected topics in chromatin structure.

Authors:  J C Eissenberg; I L Cartwright; G H Thomas; S C Elgin
Journal:  Annu Rev Genet       Date:  1985       Impact factor: 16.830

Review 6.  Functional and structural characteristics of EGF and its receptor and their relationship to transforming proteins.

Authors:  C M Stoscheck; L E King
Journal:  J Cell Biochem       Date:  1986       Impact factor: 4.429

7.  Gene amplification of c-myc and N-myc in small cell carcinoma of the lung.

Authors:  A J Wong; J M Ruppert; J Eggleston; S R Hamilton; S B Baylin; B Vogelstein
Journal:  Science       Date:  1986-07-25       Impact factor: 47.728

8.  Expression of c-myc and other cell cycle-dependent genes in human colon neoplasia.

Authors:  B Calabretta; L Kaczmarek; P M Ming; F Au; S C Ming
Journal:  Cancer Res       Date:  1985-12       Impact factor: 12.701

9.  Expression of cellular oncogenes in primary cells from human acute leukemias.

Authors:  F Mavilio; N M Sposi; M Petrini; L Bottero; M Marinucci; G De Rossi; S Amadori; F Mandelli; C Peschle
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

10.  Differential expression of myc family genes during murine development.

Authors:  K A Zimmerman; G D Yancopoulos; R G Collum; R K Smith; N E Kohl; K A Denis; M M Nau; O N Witte; D Toran-Allerand; C E Gee
Journal:  Nature       Date:  1986 Feb 27-Mar 5       Impact factor: 49.962

View more
  257 in total

1.  In vitro and in vivo growth inhibition of human malignant astrocytoma cells by the farnesyltransferase inhibitor B1620.

Authors:  Masanori Kurimoto; Yutaka Hirashima; Hideo Hamada; Hironaga Kamiyama; Shoichi Nagai; Nakamasa Hayashi; Shunro Endo
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

Review 2.  Targeting Hedgehog--a cancer stem cell pathway.

Authors:  Akil A Merchant; William Matsui
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

3.  Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma.

Authors:  David A Reardon; James J Vredenburgh; Annick Desjardins; Katherine B Peters; Sith Sathornsumetee; Stevie Threatt; John H Sampson; James E Herndon; April Coan; Frances McSherry; Jeremy N Rich; Roger E McLendon; Steven Zhang; Henry S Friedman
Journal:  J Neurooncol       Date:  2012-03-10       Impact factor: 4.130

Review 4.  Molecular genetics of neurological tumours.

Authors:  R Y Chung; B R Seizinger
Journal:  J Med Genet       Date:  1992-06       Impact factor: 6.318

5.  Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas.

Authors:  N Sugawa; A J Ekstrand; C D James; V P Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

Review 6.  Roles for growth factors in cancer progression.

Authors:  Esther Witsch; Michael Sela; Yosef Yarden
Journal:  Physiology (Bethesda)       Date:  2010-04

7.  Growth effects of epidermal growth factor (EGF) and a monoclonal antibody against the EGF receptor on four glioma cell lines.

Authors:  M H Werner; P A Humphrey; D D Bigner; S H Bigner
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 8.  EGFR-targeted therapies in the post-genomic era.

Authors:  Mary Jue Xu; Daniel E Johnson; Jennifer R Grandis
Journal:  Cancer Metastasis Rev       Date:  2017-09       Impact factor: 9.264

9.  Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas.

Authors:  F Yamaguchi; H Saya; J M Bruner; R S Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

Review 10.  Genomic stability and instability in different neuroepithelial tumors. A role for chromosome structure?

Authors:  L Manuelidis
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.